The synthesis of cryptophycins

被引:34
作者
Eissler, Stefan [1 ]
Stoncius, Arvydas [1 ]
Nahrwold, Markus [1 ]
Sewald, Norbert [1 ]
机构
[1] Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33615 Bielefeld, Germany
来源
SYNTHESIS-STUTTGART | 2006年 / 22期
关键词
drugs; medicinal chemistry; natural products; peptides; total synthesis;
D O I
10.1055/s-2006-950332
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Nature provides a huge reservoir of highly diverse chemical compounds with interesting biological properties. Secondary metabolites continue to represent promising candidates for therapeutic applications and drugs are very often based on natural products. Frequently, the total synthesis of such compounds is a real challenge, and this also drives the development of new synthetic methodology. This review article focuses on the biochemistry and chemistry of cryptophycins, a class of 16-membered macrocyclic depsipeptides. The first representative was isolated more than 15 years ago from cyanobacteria. With respect to structure, the class can be subdivided into two structural categories, containing either an epoxide or an alkene moiety. The bioactivity of cryptophycins is based on their ability to interact with tubulin. They display considerable tumour-selective cytotoxicity both against multidrug-resistant tumour cell lines and solid tumours implanted in mice. Consequently, cryptophycin derivatives are considered as potential antitumour drugs. Despite the fact that the cryptophycins were discovered only recently, several different synthetic approaches have already been published. In addition to information on the synthesis of the subunits A-D, strategies for both their assembly and the macrocyclisation are compiled in this review. 1 Structural and Biological Features of Cryptophycins 1.1 The Cryptophycins: A Short History 1.2 Structural Features 1.3 Tubulin as a Drug Target 1.4 Biological Activity of Cryptophycins 1.5 Structure-Activity Relationship 2 Synthesis of the Building Blocks 2.1 Syntheses of Unit A with Two Stereogenic Centres 2.2 Syntheses of Unit A with Four Stereogenic Centres 2.3 Units B, C, and D 3 Coupling of Units and Cyclisation 3.1 Cyclisation between Units C and B 3.2 Cyclisation between Units A and B 3.3 Homer-Wadsworth-Emmons Reaction and Ring-Closing Metathesis 3.4 Other Cyclisation Methods 4 Epoxidation 4.1 m-Chloroperoxybenzoic Acid 4.2 Dimethyldioxirane 4.3 Diol-Epoxide Conversion 4.4 Halohydrins 5 Reactions of Cryptophycins 6 Conclusion and Outlook.
引用
收藏
页码:3747 / 3789
页数:43
相关论文
共 101 条
[41]  
GOLAKOTI T, 1994, J AM CHEM SOC, V0116, P04729
[42]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[43]   Interactions of antimitotic peptides and depsipeptides with tubulin [J].
Hamel, E .
BIOPOLYMERS, 2002, 66 (03) :142-160
[44]  
Hamel Ernest, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P19, DOI 10.2174/1568011023354263
[45]   Synthesis of cryptophycin 52 using the Shi epoxidation [J].
Hoard, DW ;
Moher, ED ;
Martinelli, MJ ;
Norman, BH .
ORGANIC LETTERS, 2002, 4 (10) :1813-1815
[46]  
Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO
[47]  
2-T
[48]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[49]   Interaction of cryptophycin 1 with tubulin and microtubules [J].
Kerksiek, K ;
Mejillano, MR ;
Schwartz, RE ;
George, GI ;
Himes, RH .
FEBS LETTERS, 1995, 377 (01) :59-61
[50]  
KOBAYASHI M, 1994, CHEM PHARM BULL, V42, P2196